HB307 Summary

• Authorizes certified registered nurse practitioners (CRNPs) and certified nurse midwives (CNMs) with collaborative practice agreements to prescribe Schedule III, IV, and V controlled substances upon obtaining a Qualified Alabama Controlled Substances Registration Certificate (QACSC) from the Board of Medical Examiners.

• Requires CRNPs and CNMs to complete board-approved pharmacology courses and document 12 or more months of active clinical practice under an approved collaborative practice agreement before obtaining a QACSC.

• Establishes the Board of Medical Examiners as the certifying authority for QACSC issuance, renewal, suspension, and revocation, with grounds for denial including fraud, drug-related convictions, excessive prescribing, and substance abuse.

• Authorizes the board to charge fees for QACSC registration congruent with other mid-level providers and provides immunity to board members and agents regarding investigations and proceedings.

• Allows the Board of Medical Examiners discretionary authority to create a Limited Purpose Schedule II Permit (LPSP) for CRNPs, CNMs, and physician assistants to prescribe Schedule II substances in limited specific circumstances.

• Amends the Controlled Substances Prescription Database to grant Board of Medical Examiners access to inquire about CRNPs and CNMs holding a QACSC and allows practitioners to access database information about CRNPs and CNMs they oversee.